Literature DB >> 12232963

Methadone maintenance treatment, criminality and overdose-related deaths. An ecological study, 1983-1999.

Gérard Niveau1, Anne-Laure Rougemont, Romano La Harpe.   

Abstract

BACKGROUND: Methadone maintenance treatments (MMTs) are the commonest substitution treatments offered to opiate addiction in Switzerland, in order to reduce criminal behaviour, infectious disease transmission and overdose death.
METHOD: To investigate the relationship between the increase in the number of methadone maintenance treatments, criminal activity of addicts and overdose-related deaths, an ecological study was undertaken in the Canton of Geneva, from 1983 to 1999.
RESULTS: The regular and extensive increase in the number of MMTs is not significantly associated, during the 1983-1999 period, with a fall either in drug addict incarcerations or in overdose-related deaths. However, a slight decrease is observed in the number of imprisoned opiate addicts since 1994, and a marked decrease is seen in overdose deaths from 1997 on. An important and stable number of these deaths is due to methadone itself.
CONCLUSION: Public health objectives to diminish delinquency and overdose deaths cannot solely be fulfilled by extensive use of MMTs. A positive result could appear when access to MMT is highly favoured. This hypothesis must be proved correct by observational studies conducted on a general population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12232963     DOI: 10.1093/eurpub/12.3.224

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  2 in total

Review 1.  Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Authors:  Silvia S Martins; Laura Sampson; Magdalena Cerdá; Sandro Galea
Journal:  Am J Public Health       Date:  2015-11       Impact factor: 9.308

2.  [Drug-induced malignant arrhythmias. IT prevents lethal drug mixtures].

Authors:  S Thaler; C Neumeier; G Flury
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.